Tokyo, Nov. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059747) titled 'An observational study on treatments for postural abnormalities in Parkinson's disease and related disorders' on Nov. 12.
Study Type:
Observational
Primary Sponsor:
Institute - National Research and Development Agency, NNational Center of Neurology and Psychiatry
Condition:
Condition - Parkinson's disease and related disorders
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - A medical record review will be conducted at the NCNP to examine the treatment methods and duration of therapy for postural abnormalities. The aim is to evaluate the efficacy and safety of these treatments.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients who received treatment for postural abnormalities at our hospital by March 31, 2030, after the start of the study.
2. Patients who received an explanation of this study, understood its purpose, and provided informed consent to participate.
Key exclusion criteria - 1. Individuals who are minors or who are unable to express their intention to provide informed consent.
2. Individuals deemed inappropriate for inclusion by the principal investigator.
Target Size - 300
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 05 Month 02 Day
Date of IRB - 2025 Year 05 Month 02 Day
Anticipated trial start date - 2025 Year 05 Month 02 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068324
Disclaimer: Curated by HT Syndication.
